A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. / Thøgersen, Helle-Merete Vissing; Sørensen, B S; Poulsen, S S; Orntoft, T F; Wolf, H; Nexo, E; Poulsen, Steen Seier.
I: Cancer Research, Bind 61, Nr. 16, 15.08.2001, s. 6227-33.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients
AU - Thøgersen, Helle-Merete Vissing
AU - Sørensen, B S
AU - Poulsen, S S
AU - Orntoft, T F
AU - Wolf, H
AU - Nexo, E
AU - Poulsen, Steen Seier
PY - 2001/8/15
Y1 - 2001/8/15
N2 - Members of the epidermal growth factor (EGF) family have been suggested as prognostic markers in patients with bladder cancer. Thus far, there has been no consensus on their usefulness. We report an analysis of six ligands and two receptors of which a subset correlate to tumor stage and survival. Biopsies from bladder cancer tumors were obtained from 73 patients followed for a median of 28 months. The mRNA content for six ligands [EGF, transforming growth factor alpha (TGF-alpha), amphiregulin (AR), betacellulin (betaCL), heparin-binding EGF-like growth factor (HB-EGF), epiregulin (EPI)] and two receptors [EGF receptor I Human EGF Receptor (HER1) and 2 (HER2)] was examined by a newly developed quantitative reverse transcription-PCR method. Five ligands and two receptors (HER1 and HER2) were present in median concentrations of (10(-21) mol/microg RNA) 0.39 (AR), 11 (betaCL), 2.4 (EPI), 40 (HB-EGF), 1.4 (TGF-alpha), 75 (HER1), and 39,000 (HER2). EGF was barely detectable. A significantly higher expression of EPI (P <0.001), HB-EGF (P <0.001), and TGF-alpha (P <0.05) were observed in T2-T4 tumors as compared with Ta tumors. Especially the expression of EPI mRNA correlated strongly to survival (P <0.0005), but increased expression of TGF-alpha (P <0.005), AR, and HB-EGF (P <0.02) was also associated with a reduced life span. For the first time, mRNA expression of six ligands and two receptors of the EGF family have been examined in bladder cancer tumors. Our data emphasize that members of the EGF family, especially EPI, may be potential bladder tumor markers.
AB - Members of the epidermal growth factor (EGF) family have been suggested as prognostic markers in patients with bladder cancer. Thus far, there has been no consensus on their usefulness. We report an analysis of six ligands and two receptors of which a subset correlate to tumor stage and survival. Biopsies from bladder cancer tumors were obtained from 73 patients followed for a median of 28 months. The mRNA content for six ligands [EGF, transforming growth factor alpha (TGF-alpha), amphiregulin (AR), betacellulin (betaCL), heparin-binding EGF-like growth factor (HB-EGF), epiregulin (EPI)] and two receptors [EGF receptor I Human EGF Receptor (HER1) and 2 (HER2)] was examined by a newly developed quantitative reverse transcription-PCR method. Five ligands and two receptors (HER1 and HER2) were present in median concentrations of (10(-21) mol/microg RNA) 0.39 (AR), 11 (betaCL), 2.4 (EPI), 40 (HB-EGF), 1.4 (TGF-alpha), 75 (HER1), and 39,000 (HER2). EGF was barely detectable. A significantly higher expression of EPI (P <0.001), HB-EGF (P <0.001), and TGF-alpha (P <0.05) were observed in T2-T4 tumors as compared with Ta tumors. Especially the expression of EPI mRNA correlated strongly to survival (P <0.0005), but increased expression of TGF-alpha (P <0.005), AR, and HB-EGF (P <0.02) was also associated with a reduced life span. For the first time, mRNA expression of six ligands and two receptors of the EGF family have been examined in bladder cancer tumors. Our data emphasize that members of the EGF family, especially EPI, may be potential bladder tumor markers.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Epidermal Growth Factor
KW - Female
KW - Glycoproteins
KW - Growth Substances
KW - Humans
KW - Immunohistochemistry
KW - Intercellular Signaling Peptides and Proteins
KW - Ligands
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Prospective Studies
KW - RNA, Messenger
KW - Receptor, Epidermal Growth Factor
KW - Receptor, erbB-2
KW - Transforming Growth Factor alpha
KW - Tumor Markers, Biological
KW - Urinary Bladder Neoplasms
M3 - Journal article
C2 - 11507076
VL - 61
SP - 6227
EP - 6233
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 16
ER -
ID: 33793240